लोड हो रहा है...
Comparison of Raltegravir and Elvitagravir on HIV-1 Integrase Catalytic Reactions and on a Series of Drug-Resistant Integrase Mutants
HIV-1 integrase (IN) is the molecular target of the newly approved anti-AIDS drug raltegravir (MK-0518, Isentress(®))) while elvitegravir (GS-9137, JTK-303) is in clinical trials. The aims of the present study were: 1/ to investigate and compare the effects of raltegravir and elvitegravir on the thr...
में बचाया:
| मुख्य लेखकों: | , , , , , |
|---|---|
| स्वरूप: | Artigo |
| भाषा: | Inglês |
| प्रकाशित: |
2008
|
| विषय: | |
| ऑनलाइन पहुंच: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2660605/ https://ncbi.nlm.nih.gov/pubmed/18702518 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/bi800791q |
| टैग : |
टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!
|